USANA Health Sciences, Inc.
USNA
$33.08
$0.120.36%
| 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.68% | -36.92% | -1.37% | 47.76% | -34.38% |
| Total Depreciation and Amortization | -2.51% | 12.16% | 4.37% | -5.58% | 0.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.82% | -146.87% | -2.02% | 56.57% | 208.94% |
| Change in Net Operating Assets | 286.70% | 59.95% | -245.65% | -514.07% | 109.60% |
| Cash from Operations | 269.64% | -54.82% | -32.05% | 17.04% | 132.79% |
| Capital Expenditure | 10.18% | 16.56% | 56.29% | -403.71% | 59.71% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 50.00% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 229.31% | -- | -- | -100.00% |
| Cash from Investing | -51.23% | 62.00% | 44.44% | -403.58% | -912.29% |
| Total Debt Issued | -101.30% | -71.32% | -32.20% | -- | -100.00% |
| Total Debt Repaid | 100.20% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -154.84% | 99.75% | -9,215.67% | 98.85% | -21,065.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 94.24% | 88.67% | -1,915.50% | 105.65% | -21,065.45% |
| Foreign Exchange rate Adjustments | 633.07% | 73.17% | -193.73% | 280.06% | 55.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 700.34% | 290.14% | -109.14% | 240.35% | 50.43% |
